Key facts
- Notable investors include Guangdong Technology Financial Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Anye Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Anye Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Anye Pharmaceutical
Developer of a pharmaceutical product intended to advance treatment options for neurological disorders. The company offers a dedicated research team and cutting-edge technology, enabling patients with neurological conditions to access more effective and targeted therapies.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Anye Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Anye Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Anye Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.